Evidence map›Paper›PMID 38438204›Full record

ArticleSaudi medical journal2024

The epidemiological and clinicopathological features of breast cancer in Riyadh, Saudi Arabia.

Ahmad Aa Omer, Salman A Bin Dayel, Ali Sa Hummedi, Noura Ia Almuhaimed

Abstract read
In one paragraph

Article in Saudi medical journal, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ahmad Aa OmerFrom the Department of Surgery (Omer) and Department of Medicine (Bin Dayel), Faculty of Medicine, Prince Sattam Bin Abdulaziz University, Al Kharj; from the Department of Medical Oncology (Hummedi), King Fahad Medical City; and from the MRI Department (Almuhaimed), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.ORCID https://orcid.org/0000-0001-8311-8888
Salman A Bin DayelFrom the Department of Surgery (Omer) and Department of Medicine (Bin Dayel), Faculty of Medicine, Prince Sattam Bin Abdulaziz University, Al Kharj; from the Department of Medical Oncology (Hummedi), King Fahad Medical City; and from the MRI Department (Almuhaimed), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
Ali Sa HummediFrom the Department of Surgery (Omer) and Department of Medicine (Bin Dayel), Faculty of Medicine, Prince Sattam Bin Abdulaziz University, Al Kharj; from the Department of Medical Oncology (Hummedi), King Fahad Medical City; and from the MRI Department (Almuhaimed), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.
Noura Ia AlmuhaimedFrom the Department of Surgery (Omer) and Department of Medicine (Bin Dayel), Faculty of Medicine, Prince Sattam Bin Abdulaziz University, Al Kharj; from the Department of Medical Oncology (Hummedi), King Fahad Medical City; and from the MRI Department (Almuhaimed), King Fahad Medical City, Riyadh, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo investigate the epidemiological and clinicopathological features of breast cancer (BC) in Saudi Arabia to improve decisions regarding resource allocation, disease control, and management.

methodsWe retrieved the records of all patients who presented with histologically proven BC at King Fahad Medical City between 2019 and 2020. The data were analyzed quantitatively, and the results were expressed as percentages and frequencies.

resultsThis study comprised 419 patients. The mean age was 50.13 (± 10.96) years. The majority of the patients were obese (56.6%), and approximately a quarter had a history of oral contraceptive pill use, breast biopsy, or an affected family member. Most cases were from the central region (80.1%), followed by the southern provinces (12.7%). Breast lumps were the most common complaint (89%), whereas hypertension and diabetes mellitus were the most common comorbidities. Invasive ductal carcinoma was the most common pathologic type (89.7%). Most patients presented with TNM stages II and III (55.2%), and 27.7% had metastasis. The main therapeutic modalities included radical mastectomy (63.8%), neoadjuvant chemotherapy (60.4%), and adjuvant radiotherapy (82.9%).

conclusionIn Saudi Arabia, a trend of BC incidence migration towards older patients may be ensuing. However, prediction of an advanced and aggressive presentation requires the enhancement of screening programs and standardized protocols for disease management.

Indexed as

Breast NeoplasmsBiopsyFamilyFemaleHumansMastectomyMiddle AgedSaudi ArabiaBreast cancerclinico-pathologicepidemiologyRiyadhSaudi Arabia

Identifiers

PMID38438204
PMCPMC11115392

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.